VRC01 Pharmacokinetics at Mucosal Sites in HIV-infected and Healthy Adults

被引：0
|
作者：
Prabhakaran, Madhu S. P. [1 ]
Narpala, Sandeep R. [1 ]
Lin, Chien L. [1 ]
Bailer, Robert T. [1 ]
Shi, Wei [1 ]
Chen, Xuejun [1 ]
Kong, Wing-Pui [1 ]
Ledgerwood, Julie [1 ]
Koup, Richard A. [1 ]
McDermott, Adrian B. [1 ]
机构：
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OA08.04
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults
    Huang, Yunda
    Zhang, Lily
    Ledgerwood, Julie
    Grunenberg, Nicole
    Bailer, Robert
    Isaacs, Abby
    Seaton, Kelly
    Mayer, Kenneth H.
    Capparelli, Edmund
    Corey, Larry
    Gilbert, Peter B.
    MABS, 2017, 9 (05) : 792 - 800
  • [2] Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
    Ledgerwood, J. E.
    Coates, E. E.
    Yamshchikov, G.
    Saunders, J. G.
    Holman, L.
    Enama, M. E.
    DeZure, A.
    Lynch, R. M.
    Gordon, I.
    Plummer, S.
    Hendel, C. S.
    Pegu, A.
    Conan-Cibotti, M.
    Sitar, S.
    Bailer, R. T.
    Narpala, S.
    McDermott, A.
    Louder, M.
    O'Dell, S.
    Mohan, S.
    Pandey, J. P.
    Schwartz, R. M.
    Hu, Z.
    Koup, R. A.
    Capparelli, E.
    Mascola, J. R.
    Graham, B. S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 (03): : 289 - 301
  • [3] VRC01 antibody prevention of HIV
    Corey, L.
    Gilbert, P. B.
    Mgodi, N. M.
    Edupuganti, S.
    Cohen, M. S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [4] HIV Broadly Neutralizing Antibodies: VRC01 and Beyond
    Wu, Xueling
    HIV VACCINES AND CURE: THE PATH TOWARDS FINDING AN EFFECTIVE CURE AND VACCINE, 2018, 1075 : 53 - 72
  • [5] Safety and Pharmacokinetics of Multiple Doses of a Potent Anti-HIV Monoclonal Antibody, VRC01, in HIV-exposed Newborns
    Cunningham, Coleen
    McFarland, Elizabeth
    Capparelli, Edmund
    Muresan, Petronella
    Perlowski, Charlotte
    Morrison, Leavitt
    Morgan, Patricia
    Smith, Betsy
    Mascola, John
    Graham, Barney
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 36 - 36
  • [6] Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach
    Li, Jerry
    Nikanjam, Mina
    Cunningham, Coleen K.
    McFarland, Elizabeth J.
    Coates, Emily E.
    Houser, Katherine V.
    Lin, Bob C.
    McDermott, Adrian B.
    Flach, Britta
    Gama, Lucio
    Koup, Richard A.
    Graham, Barney S.
    Mascola, John R.
    Ledgerwood, Julie E.
    Capparelli, Edmund V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (01) : 184 - 192
  • [7] Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
    Bar, K. J.
    Sneller, M. C.
    Harrison, L. J.
    Justement, J. S.
    Overton, E. T.
    Petrone, M. E.
    Salantes, D. B.
    Seamon, C. A.
    Scheinfeld, B.
    Kwan, R. W.
    Learn, G. H.
    Proschan, M. A.
    Kreider, E. F.
    Blazkova, J.
    Bardsley, M.
    Refsland, E. W.
    Messer, M.
    Clarridge, K. E.
    Tustin, N. B.
    Madden, P. J.
    Oden, K. S.
    O'Dell, S. J.
    Jarocki, B.
    Shiakolas, A. R.
    Tressler, R. L.
    Doria-Rose, N. A.
    Bailer, R. T.
    Ledgerwood, J. E.
    Capparelli, E. V.
    Lynch, R. M.
    Graham, B. S.
    Moir, S.
    Koup, R. A.
    Mascola, J. R.
    Hoxie, J. A.
    Fauci, A. S.
    Tebas, P.
    Chun, T-W
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2037 - 2050
  • [8] Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials
    Huang, Yunda
    Naidoo, Logashvari
    Zhang, Lily
    Carpp, Lindsay N.
    Rudnicki, Erika
    Randhawa, April
    Gonzales, Pedro
    McDermott, Adrian
    Ledgerwood, Julie
    Lorenzo, Margarita M. Gomez
    Burns, David
    DeCamp, Allan
    Juraska, Michal
    Mascola, John
    Edupuganti, Srilatha
    Mgodi, Nyaradzo
    Cohen, Myron
    Corey, Lawrence
    Andrew, Philip
    Karuna, Shelly
    Gilbert, Peter B.
    Mngadi, Kathryn
    Lazarus, Erica
    EBIOMEDICINE, 2021, 64
  • [9] Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
    Li, Yuxing
    O'Dell, Sijy
    Walker, Laura M.
    Wu, Xueling
    Guenaga, Javier
    Feng, Yu
    Schmidt, Stephen D.
    McKee, Krisha
    Louder, Mark K.
    Ledgerwood, Julie E.
    Graham, Barney S.
    Haynes, Barton F.
    Burton, Dennis R.
    Wyatt, Richard T.
    Mascola, John R.
    JOURNAL OF VIROLOGY, 2011, 85 (17) : 8954 - 8967
  • [10] VRC01 provides sterilizing protection to non human primates from mucosal SHIV challenges
    Pegu, Amarendra
    Yang, Zhi-yong
    Chen, Xuejen
    Todd, John-Paul
    McKee, Krisha
    Rao, Srinivas
    Mascola, John
    Nabel, Gary
    JOURNAL OF IMMUNOLOGY, 2011, 186
12345